215 related articles for article (PubMed ID: 8730407)
1. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
Bagrov AY; Fedorova OV; Dmitrieva RI; French AW; Anderson DE
Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
[TBL] [Abstract][Full Text] [Related]
2. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
Fedorova OV; Doris PA; Bagrov AY
Clin Exp Hypertens; 1998; 20(5-6):581-91. PubMed ID: 9682914
[TBL] [Abstract][Full Text] [Related]
3. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
[TBL] [Abstract][Full Text] [Related]
4. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
5. Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.
Bagrov AY; Fedorova OV; Austin-Lane JL; Dmitrieva RI; Anderson DE
Hypertension; 1995 Nov; 26(5):781-8. PubMed ID: 7591018
[TBL] [Abstract][Full Text] [Related]
6. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
Fedorova OV; Anderson DE; Bagrov AY
Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
[TBL] [Abstract][Full Text] [Related]
7. [Variations in the plasma concentrations of atrial natriuretic factor and endogenous digitalis compounds during acute volume expansion in the conscious rat].
Morris M; Devynck MA; Pernollet MG; Meyer P
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():105-8. PubMed ID: 2847669
[TBL] [Abstract][Full Text] [Related]
8. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
9. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
Fedorova OV; Bagrov AY
Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
Pullen MA; Brooks DP; Edwards RM
J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
[TBL] [Abstract][Full Text] [Related]
12. Bile salts as endogenous digitalis like factors.
Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
[TBL] [Abstract][Full Text] [Related]
13. Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly.
Deray G; Rieu M; Devynck MA; Pernollet MG; Chanson P; Luton JP; Meyer P
N Engl J Med; 1987 Mar; 316(10):575-80. PubMed ID: 3027557
[TBL] [Abstract][Full Text] [Related]
14. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
[TBL] [Abstract][Full Text] [Related]
15. Endogenous glycosides in critically ill patients.
Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.
Bagrov AY; Fedorova OV; Dmitrieva RI; Howald WN; Hunter AP; Kuznetsova EA; Shpen VM
Hypertension; 1998 May; 31(5):1097-103. PubMed ID: 9576120
[TBL] [Abstract][Full Text] [Related]
17. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
[TBL] [Abstract][Full Text] [Related]
18. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
[TBL] [Abstract][Full Text] [Related]
19. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
20. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
Schoner W; Scheiner-Bobis G
Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
